Nunn Jason Raleigh

Nunn Jason Raleigh is listed in filings as Director at Zenas BioPharma, Inc.. This profile follows SEC Form 4 activity through Oct 14, 2025, including purchase activity. Recent filings connect the profile to Zenas BioPharma, Inc. (ZBIO) and Regulus Therapeutics Inc. (RGLS). The current snapshot covers public activity from Apr 30, 2025 to Oct 14, 2025. Reported amounts are shown as $220.9K to $29.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.